Serina Therapeutics to Present at the 14th Annual Injectables Summit
Serina Therapeutics, Inc. (SER)
Company Research
Source: GlobeNewswire
HUNTSVILLE, AL, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform™ drug delivery technology, announced that Serina Therapeutics' Chief Development Officer, Randall Moreadith, MD, PhD, will be presenting today at the 14th Annual Injectables Summit in Boston, MA. The joint presentation, with Enable Injections’ Chief Commercial Officer Matthew Huddleston, is entitled “Patient-enabled Therapy for Advanced Parkinson's Disease - A Case Study with Serina Therapeutics' SER-252 + Enable Injections' enFuse Wearable Drug Delivery Platform”. Dr. Moreadith and Mr. Huddleston will share how their teams are partnering together to provide life-changing therapeutics with comfortable and convenient delivery to those living with advanced Parkinson’s Disease. About Serina Therapeutics Serina is a clinical-stage biotechnology company developing a pipeline of wholly owned drug prod
Show less
Read more
Impact Snapshot
Event Time:
SER
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SER alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SER alerts
High impacting Serina Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
SER
News
- Serina Therapeutics to Present at Tribe Public's Webinar Event "Enabling Continuous Drug Delivery for Parkinson's Disease & Beyond" on Wednesday, December 18, 2024 [Yahoo! Finance]Yahoo! Finance
- Serina Therapeutics to Present at Tribe Public’s Webinar Event "Enabling Continuous Drug Delivery for Parkinson's Disease & Beyond" on Wednesday, December 18, 2024GlobeNewswire
- Serina Therapeutics to Present at the 3rd Annual LNP Immunogenicity & Toxicity Summit [Yahoo! Finance]Yahoo! Finance
- Serina Therapeutics to Present at the 3rd Annual LNP Immunogenicity & Toxicity SummitGlobeNewswire
- Serina Therapeutics Secures $10 Million Financing to Continue Advancing Lead IND Candidate into Phase 1 Clinical Trial in Advanced Parkinson's Disease PatientsGlobeNewswire
SER
Sec Filings
- 12/26/24 - Form 8-K
- 12/18/24 - Form 8-K
- 12/11/24 - Form 8-K
- SER's page on the SEC website